Treatment of spinal cord injury, by restoration of neuronal networks using a combination of surgery and KCL-286, an orally available retinoic acid receptor ß drug (2026)
Attributed to:
A phase 1 trial of a retinoic acid receptor beta agonist for the treatment of spinal cord injury
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fsurg.2026.1743444
Publication URI: http://dx.doi.org/10.3389/fsurg.2026.1743444
Type: Journal Article/Review
Parent Publication: Frontiers in Surgery